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TGF-β1 in each group. The apoptotic rate of hepatic cells in B
was signiﬁcantly reduced than that of C.
Conclusion: Anti-IGFBP-rP1 can prevent the progression of hep-
atic ﬁbrosis through inhibiting activation of HSC, reducing the
expressions of Collagen I and FN, reducing hepatocyte apop-
tosis and so on. The possible mechanism may relate to the
TGF-β1/Smad3 signal path.
PP-036 Dynamic changes of both IGFBPrP1 and
transforming growth factorβ1/Smad on liver
tissue with ﬁbrosis in mice
Lixin Liu*,1,2, Qianqian Zhang1, Haiyan Zhang1, Yongqiang Shi 1.
1The First Hospital of Shanxi Medical University; 2The Institute
of Liver Disease of Shanxi Medical University
Background: To investigate dynamic expressions of IGFBPrP1,
TGF β1 and Smad3 of mice with thioacetamide (TAA) - induced
hepatic ﬁbrosis.
Methods: Liver ﬁbrosis model of mice was made by intraperi-
toneal injecting with 5% TAA, 200mg/kg, three times per week,
totally for 4 or 5 or 6 weeks. Collagen accumulation in liver tis-
sues was detected by Masson staining. Distribution and dynamic
expressions of IGFBPrP1, α-SMA, Collagen I, FN, TGFβ1, Smad3
were detected by immunohistochemistry staining. Meanwhile,
expressions of IGFBPrP1, α-SMA, FN and Smad3 were examined
by Western Blot.
Result: During the progression of hepatic ﬁbrosis, expressions of
Collagen, IGFBPrP1, α-SMA, Collagen I, FN, TGFβ1, Smad3 were
gradually increased.Correlation analysis of immunohistochemi-
cal staining: during liver ﬁbrosis developing phases, IGFBPrP1
was signiﬁcantly positively correlated withα-SMA, Collagen I,
FN, TGFβ1, Smad3. The results of Western Blot analysis: Molec-
ular weight of β-actin, IGFBPrP1, α-SMA, FN, Smad3were 43,
31, 45, 220 and 58kD. The contents of IGFBPrP1, α-SMA, FN,
Smad3 were signiﬁcantly increased in model group compared
with control group, which were gradually increased with pro-
cess of ﬁbrosis. There was a signiﬁcant difference among model
group. Correlation analysis of Western Blot analysis: There was a
positive correlation between the expression of IGFBPrP1and the
expression of α-SMA, FN, Smad3.
Conclusion: IGFBPrP1 was involved in the formation and de-
velopment of hepatic ﬁbrosis; Meanwhile, this function of IGF-
BPrP1 probably relates to promote activation of HSC; promote
the synthesis and secretion of both collagenI and FN; affect
TGFβ1/Smad3 pathway.
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PP-037 Screening of speciﬁc serum biomarker of
anklosing spondylitis from a random peptide
library
Min Wang*, Xianping Li. Department of Clinical Laboratory, The
Second Xiangya Hospital of Central South University
Objective: To screen the speciﬁc serum biomarker of anklosing
spondylitis using peptide library biopanning technique.
Methods: Phage random peptide library of 12 amino acids was im-
munoscreenedwith puriﬁed IgG from sera of anklosing spondylitis
(AS) patients. Positive clones which were obtained after 3 rounds
of biopanning were detected by ELISA and 7 of them were se-
quenced. The binding test of positive clones with the AS patients,
systemic lupus erythematosus (SLE) patients, rheumatoid arthri-
tis (RA) patients, Osteoarthritis (OA) patients as well as healthy
controls were detected using phage-ELISA. The correlation anal-
yses were evaluated among the absorbance and erythrocyte
sedimentation rate (ESR) and C- reactive protein (CRP).
Result: After 3 rounds of screening, the radio of output to input
increase to 1.9×10-5. At the 3rd round of screening, 20 clones
were selected and 17 were proved to speciﬁcally react with the
sera of AS patients. The 7 clones sequenced were come from
the same one named AS1. Its inserted sequence was deduced to
be QSQRRARSIMMM. The positive rate of AS1 in diagnosis AS pa-
tients, SLE patients, RA patients, OA patients and healthy control
group was 92.0%, 56.7%, 50.0%, 13.3% and 14.0% respectively,
and there was signiﬁcant difference (χ2=77.418, P< 0. 01). The
absorbance values showed positive correlation with ESR and CRP,
the correlation coefﬁcients were 0.165 and 0.239.
Conclusion: These ﬁnding indicated that the short peptide QSQR-
RARSIMMM could be the speciﬁc serum biomarker of AS and may
be used in laboratory test.
PP-038 Dynamic expression of hypoxia inducible
factor-1α during the development of
hepatocellular carcinoma and its clinical values
Liwei Qiu*, Jing Qian, Dengfu Yao. Research Center of Clinical
Medicine, Afﬁliated Hospital of Nantong University, Nantong,
China
Objective: To investigate the dynamic expression and alter-
ation of hypoxia inducible factor-1α (HIF-1α) and its pathological
features in hepotacellular carcinoma (HCC).
Methods: Hepatomas model was induced with 2-FAA on male SD
rats for investigating dynamic changes of HIF-1α. Liver specimen
from HCC patients were collected by self-control method. The
expression, cellular distribution, and pathological features of
HIF-1αwere analyzed by immohistochemistry.
Results: Rat hepatocytes from granule-like degeneration to
atypical hyperplasia and HCC development, and the progressing
increasing of the levels of hepatic HIF-1α and HIF-1α mRNA
expression during the course. The levels of HIF-1α in hepatoma
tissues and sera were signiﬁcantly higher than those in normal
and degeneration ones. There was positive relationship of HIF-1α
levels between them in hepatoma tissues and sera (P<0.05). The
positive HIF-1αw as brown and granule-like, mainly presented in
cytoplasm and few in nucleus. The incidence was 80% (28/35) in
HCC, and 100% (35/35) in its surrounding tissues (P<0.001), re-
spectively. The clinical pathological features of HIF-1α expression
demonstrated that it correlated with tumor size, and its intensity
was negative correlated with the differentiation of HCC. No cor-
relation was found between HIF-1αand tumor numbers or serum
AFP level or positive-HBsAg.
Conclusions: Hepatic HIF-1α overexpression are associated with
development and prognosis of HCC.
PP-039 Determine the new serotype 6C Streptococcus
pneumoniae by serological method
Zunjie Liu*, Kaihu Yao, Lin Yuan, Wei Gao, Sangjie Yu,
Yonghong Yang. Beijing Pediatric Research Institute, Beijing
Children’s Hospital afﬂiated to Capital Medical University
Objective: To prepare serotype 6C diagnostic Streptococcus
pneumoniae antiserum, to determine it was a new serotype.
Methods: Serotype 6C was determined in USA by using multibean
assay.Immunizing rabbits with serotype 6C pneumococcal strains
for 0ne month. Detected the capsular titres of antiserumwith 6A,
6B and 6C before absorbed and latter by cross-reaction strains.
Results: None capsular reactions were detected from the an-
Table 1. Capsular titers of serotype 6C rabbit antisera to type 6A, 6B and 6C
Antisera 1× 2× 4× 8× 16× 32× 64× 128×
6A + + + + + + + –
6B + + + + + + – –
6C + + + + + + + –
